Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H32O7 |
| Molecular Weight | 372.4532 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](CC[C@H]1C(C)=CC(=O)CC1(C)C)O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
InChI
InChIKey=NYLNHNDMNOPWAZ-ZLEFDVGRSA-N
InChI=1S/C19H32O7/c1-10-7-12(21)8-19(3,4)13(10)6-5-11(2)25-18-17(24)16(23)15(22)14(9-20)26-18/h7,11,13-18,20,22-24H,5-6,8-9H2,1-4H3/t11-,13+,14-,15-,16+,17-,18-/m1/s1
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24785825
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24785825
Byzantionoside B was isolated from the aerial parts of Stachys byzantina as the C-9 epimer of blumenol C glucoside. Byzantionoside B showed osteogenic activity by increasing alkaline phosphatase activity and calcium contents to regulate differentiation and mineralization in human osteoblast cells.
Approval Year
Sample Use Guides
Byzantionoside B significantly increased alkaline phosphatase activity in human osteoblast cells when used at a concentration of 100 μM and also increased the calcium contents of the mineralized matrix. At the same concentration. Byzantionoside B upregulated the mRNA expression of osteopontin, bone morphogenetic protein-2, and runt-related transcription factor 2 in human osteoblast cells.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
14135395
Created by
admin on Sat Dec 16 11:08:54 GMT 2023 , Edited by admin on Sat Dec 16 11:08:54 GMT 2023
|
PRIMARY | |||
|
135820-80-3
Created by
admin on Sat Dec 16 11:08:54 GMT 2023 , Edited by admin on Sat Dec 16 11:08:54 GMT 2023
|
PRIMARY | |||
|
6C3V404S0G
Created by
admin on Sat Dec 16 11:08:54 GMT 2023 , Edited by admin on Sat Dec 16 11:08:54 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
